Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Recommendation of “Moderate Buy” from Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has received an average recommendation of “Moderate Buy” from the nineteen brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $550.28.

ISRG has been the subject of a number of recent research reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Citigroup lifted their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 over the last quarter. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Large investors have recently bought and sold shares of the business. Mirador Capital Partners LP grew its stake in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares in the last quarter. Consolidated Planning Corp grew its stake in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Swiss National Bank grew its stake in Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC purchased a new stake in Intuitive Surgical during the 3rd quarter valued at about $604,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $544.72 on Friday. Intuitive Surgical has a 52 week low of $320.22 and a 52 week high of $556.23. The stock has a market capitalization of $194.02 billion, a P/E ratio of 87.40, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. The stock has a fifty day moving average of $519.37 and a 200-day moving average of $477.06.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, research analysts forecast that Intuitive Surgical will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.